21 – 30 of 72
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing : A Systematic Review
- Contribution to journal › Scientific review
-
Mark
The Lund Molecular Taxonomy Applied to Non-Muscle-Invasive Urothelial Carcinoma
- Contribution to journal › Article
-
Mark
The Urothelial Transcriptomic Response to Interferon Gamma : Implications for Bladder Cancer Prognosis and Immunotherapy
- Contribution to journal › Article
-
Mark
Immunohistochemical Assays for Bladder Cancer Molecular Subtyping : Optimizing Parsimony and Performance of Lund Taxonomy Classifiers
- Contribution to journal › Article
-
Mark
Diagnostic and prognostic implications of a three-antibody molecular subtyping algorithm for non-muscle invasive bladder cancer
- Contribution to journal › Article
-
Mark
A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer—Stromal gene expressions show higher prognostic values than intrinsic tumor genes
- Contribution to journal › Article
-
Mark
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
- Contribution to journal › Article
-
Mark
A comparison of rule-based and centroid single-sample multiclass predictors for transcriptomic classification
- Contribution to journal › Article
- 2021
-
Mark
Tumor Subtyping : Making Sense of Heterogeneity with a Goal Toward Treatment
- Contribution to journal › Scientific review
-
Mark
When the Molecular Subtype Is Hidden Behind a Veil of Stroma
- Contribution to journal › Debate/Note/Editorial
